Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPz Cussons Regulatory News (PZC)

Share Price Information for Pz Cussons (PZC)

Share Price is delayed by 15 minutes
Get Live Data
87.20    -0.20 (-0.23%)
Bid:
85.50
Ask:
88.00
Spread: 2.50 (2.924%)
Market Cap: £366.55m
PZC Live PriceLast checked at - London Stock Exchange

Intraday Pz Cussons Share Chart

Interim Management Statement

14 Apr 2011 07:00

RNS Number : 8629E
PZ CUSSONS PLC
14 April 2011
 



14 April 2011

PZ Cussons Plc

(the "Group")

 

Interim Management Statement

 

PZ Cussons Plc today issues the following interim management statement which covers the period 26th January 2011 to 13th April 2011.

 

Overview of financial performance and position

 

PZ Cussons Plc announces that results for the period have been broadly in line with management expectations, despite challenging trading conditions in some markets and continued high levels of raw material costs.

 

The Group's balance sheet remains healthy with a net funds position and good cash generation during the period.

 

Trading Update

 

Europe

 

In the UK, trading conditions remain challenging with high levels of promotional activity and a continuing squeeze on consumer spending. This is particularly noticeable in areas such as shower gels and handwash. The more premium brands under the newly formed PZ Cussons Beauty division, namely The Sanctuary, St Tropez and Charles Worthington have continued to perform well.

 

Trading conditions in Poland and Greece also remain challenging due to a difficult consumer environment.

 

Asia

 

The Asia region as a whole continues to perform strongly, and whilst the Australian consumer environment has tightened, the relaunch of Cussons Baby in Indonesia is continuing to drive profitable growth.

 

Africa

 

After some initial delays, the Nigerian election process has now begun with the presidential elections expected to be complete by the end of April. Whilst underlying sales rates during the period have improved, some further disruption to trading from the election process is expected during the remainder of the financial year coinciding with the traditionally peak sales months.

 

Exceptional Items

 

These will include transaction costs associated with the acquisition of St Tropez together with further costs associated with the restructuring of the business as anticipated.

 

In addition, exceptional items will include a charge in relation to the enhanced transfer value exercise being conducted in relation to the closed UK based final salary pension schemes and a credit reflecting the change in statutory minimum pension increases from RPI to CPI.

 

Major initiatives

 

In the UK, the formation of the PZ Cussons Beauty division which was announced in February, is on track and expected to be fully operational by 1 June.

 

In Nigeria, initial work on the food and nutrition joint venture with Wilmar International has now begun.

 

Outlook

 

The trading outlook for the remainder of the current financial year remains challenging and is expected to be impacted by the UK trading environment, the temporary delay to Nigeria's election process and continued high levels of raw material costs.

 

These factors will be partially offset by the resilience of our more premium brands in the UK, by the growth in Asia and by the underlying improvement in demand in Nigeria, all of which give cause for encouragement for the next financial year.

 

A further trading update will be made on 9th June 2011 after the close of the financial year.

 

 

Enquiries:

 

PZ Cussons Plc

Brandon Leigh Tel: 0161 435 1016

 

MHP Communications

John Olsen / James White Tel: 020 3128 8100

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSDKNDKQBKDFQD
Date   Source Headline
29th Nov 202111:25 amRNSDirector/PDMR Shareholding
25th Nov 20214:40 pmRNSDirector/PDMR Shareholding
23rd Nov 20214:05 pmRNSAnnual General Meeting
9th Nov 20217:00 amRNSDirector/PDMR Shareholding
15th Oct 20217:00 amRNSPublication of Annual Report and notice of AGM
24th Sep 20219:00 amRNSDirector/PDMR Shareholding
22nd Sep 20217:00 amRNSTrading Statement
22nd Sep 20217:00 amRNSFinal Results
13th Sep 20213:00 pmRNSAppointment of Non Executive Director
27th Jul 202111:00 amRNSDirector/PDMR Shareholding
5th Jul 20214:00 pmRNSDirector/PDMR Shareholding
1st Jul 20217:00 amRNSTrading update
29th Jun 202110:45 amRNSNotice of pre-close trading update
25th Jun 20217:00 amRNSAppointment of Non Executive Director
27th Apr 20217:00 amRNSTrading Statement
25th Mar 20217:00 amRNSCapital Markets Day
22nd Mar 20211:00 pmRNSDirector/PDMR Shareholding
22nd Feb 20215:30 pmRNSDirector/PDMR Shareholding
3rd Feb 20219:00 amRNSDirector/PDMR Shareholding
26th Jan 20217:00 amRNSHalf-year Report
1st Dec 20203:45 pmRNSDirector/PDMR Shareholding
26th Nov 20202:30 pmRNSResult of AGM
26th Nov 20207:00 amRNSDirectorate Change
23rd Oct 202012:00 pmRNSPublication of Annual Report / Notice of AGM
20th Oct 20201:00 pmRNSHolding(s) in Company
1st Oct 20208:38 amRNSCompletion of Nutricima disposal
28th Sep 20203:00 pmRNSDirector/PDMR Shareholding
23rd Sep 20207:00 amRNSTrading Statement
23rd Sep 20207:00 amRNSBoard Change
23rd Sep 20207:00 amRNSFinal Results for the year ended 31 May 2020
14th Aug 20208:50 amRNSDirector Declaration
6th Jul 20209:05 amRNSDirector Declaration
30th Jun 20205:30 pmRNSDirector/PDMR Shareholding
19th Jun 20209:29 amRNSDirector/PDMR Shareholding
5th Jun 20202:15 pmRNSRevised reporting timetable
28th May 20201:01 pmRNSDirector/PDMR Shareholding
22nd May 202010:20 amRNSDirector Declaration
28th Apr 202011:33 amRNSDirector/PDMR Shareholding
16th Apr 20207:00 amRNSTrading Update for the Third Quarter 2020
14th Apr 20204:15 pmRNSBoard Change
2nd Apr 20207:00 amRNSUpdate on Settlement Agreement with Former CEO
19th Mar 20207:00 amRNSAppointment of new Chief Executive Officer
19th Mar 20207:00 amRNSBoard changes
18th Mar 20207:00 amRNSSale of Nutricima and completion of Luksja sale
20th Feb 20207:00 amRNSHolding(s) in Company
28th Jan 20207:00 amRNSHalf-year Report
12th Dec 20197:00 amRNSDirectorate Change
12th Dec 20197:00 amRNSTrading Update
30th Oct 20197:00 amRNSAppointment of Non-executive Directors
30th Sep 201911:15 amRNSCompletion of Minerva sale

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.